Jim Hindman

Jim Hindman holds extensive board experience across various companies in the pharmaceutical and medical sectors. Currently, Jim serves as an Independent Board Member, Audit Chair, and Compensation Chair at Amolyt Pharma and as an Independent Board Member and Audit Chair at Accuray. Additionally, Jim contributes to Loyola Marymount University as a member of the Dean's Executive Council for the Business School and the Board of Regents. Past roles include independent board memberships at Aatru Medical Corporation, Urovant Sciences, MILLENDO THERAPEUTICS, and Sienna Biopharmaceuticals, as well as financial consulting for Rani Therapeutics and Cidara Therapeutics. Jim previously served as President of the Allergan Foundation. Educational credentials include a Bachelor of Science in Accounting from Loyola Marymount University and a Master of Business Administration from Pepperdine University.